Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4823 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.82 USD | -3.53% | -6.82% | -5.75% | -84.62% | 5.43 M USD | ||
| 4833 | CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 USD | +14.74% | +9.67% | +17.11% | +68.94% | 5.08 M USD | ||
| 4837 | XBIO Xenetic Biosciences, Inc. - Common Stock | 2.12 USD | -4.07% | -7.83% | -48.92% | -75.60% | 4.97 M USD | ||
| 4838 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.69 USD | -4.65% | -1.60% | +4.24% | +138.06% | 4.96 M USD | ||
| 4845 | NCNA NuCana plc - American Depositary Shares | 1.13 USD | -0.88% | -5.83% | -16.91% | -47.44% | 4.70 M USD | ||
| 4848 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.98 USD | 0.00% | -8.76% | -20.16% | +120.00% | 4.68 M USD | ||
| 4857 | ENLV Enlivex Ltd. - Ordinary Shares | 0.28 USD | -9.68% | -33.33% | -73.08% | -76.07% | 4.43 M USD | ||
| 4863 | DRMA Dermata Therapeutics, Inc. - Common Stock | 1.07 USD | -4.46% | -7.76% | -11.57% | -25.17% | 4.30 M USD | ||
| 4864 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.40 USD | -2.44% | -2.44% | -16.67% | -60.00% | 4.29 M USD | ||
| 4873 | ERNA Ernexa Therapeutics Inc. - Common Stock | 2.49 USD | +4.18% | -17.00% | -36.64% | +611.43% | 4.06 M USD | ||
| 4878 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 3.18 USD | +6.71% | +4.26% | -13.35% | -63.78% | 3.92 M USD | ||
| 4886 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.35 USD | -4.93% | -21.97% | -32.16% | -39.19% | 3.77 M USD | ||
| 4891 | GRI GRI Bio, Inc. - Common Stock | 1.68 USD | -9.19% | -16.00% | -6.15% | -36.60% | 3.67 M USD | ||
| 4897 | EVGN Evogene Ltd. - Ordinary Shares | 0.40 USD | -2.44% | -2.44% | -20.00% | -69.92% | 3.49 M USD | ||
| 4899 | SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 0.97 USD | -11.82% | -24.22% | +3.19% | -40.85% | 3.41 M USD | ||
| 4901 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 0.93 USD | -4.12% | -5.10% | -20.51% | -83.15% | 3.32 M USD | ||
| 4905 | APVO Aptevo Therapeutics Inc. - Common Stock | 1.80 USD | -2.17% | 0.00% | -2.70% | -73.33% | 3.24 M USD | ||
| 4909 | REVB Revelation Biosciences, Inc. - Common Stock | 0.78 USD | -6.02% | -3.70% | -22.00% | -43.48% | 3.11 M USD | ||
| 4912 | MLEC Moolec Science SA - Ordinary Shares | 4.19 USD | -12.89% | -13.61% | -38.38% | +398.81% | 3.04 M USD | ||
| 4918 | MBIO Mustang Bio, Inc. - Common Stock | 0.41 USD | -8.89% | -12.77% | -24.07% | -52.87% | 2.97 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |